Get the Stockscreener App
1.93
13.53%
0.23
InspireMD Inc. stock is traded at $1.93, with a volume of 283.40K.
It is up +13.53% in the last 24 hours and down -17.87% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$1.70
Open:
$1.78
24h Volume:
283.40K
Relative Volume:
2.23
Market Cap:
$81.78M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-1.8381
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
-8.53%
1M Performance:
-17.87%
6M Performance:
-13.26%
1Y Performance:
-25.19%
1-Day Range:
$1.78
$2.10
1-Week Range:
$1.69
$2.22
52-Week Range:
$1.59
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.93 | 72.03M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD (Nasdaq: NSPR) grants 122,054 inducement shares to eight new hires - Stock Titan
What catalysts could drive InspireMD Inc. stock higherEarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Is InspireMD Inc. (II2) stock suitable for passive index fundsOil Prices & Capital Protection Trade Alerts - newser.com
Can InspireMD Inc. (II2) stock survive global slowdownFed Meeting & Growth Focused Stock Pick Reports - newser.com
Why analysts remain bullish on InspireMD Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - The Manila Times
InspireMD (NASDAQ: NSPR) schedules fireside chat at Piper Sandler healthcare conference - Stock Titan
Applying sector rotation models to InspireMD Inc.Quarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
How InspireMD Inc. (II2) stock responds to job market shifts2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Applying chart zones and confluence areas to InspireMD Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Is InspireMD Inc. stock poised for growthPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
NSPR SEC FilingsInspiremd 10-K, 10-Q, 8-K Forms - Stock Titan
How InspireMD Inc. stock reacts to Fed rate cuts2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
How strong dollar benefits InspireMD Inc. (II2) stockJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
What margin trends mean for InspireMD Inc. stockEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Short interest data insights for InspireMD Inc.Market Trend Summary & Consistent Income Trade Ideas - newser.com
InspireMD Q3 2025 Earnings Preview - MSN
What to do if you’re stuck in InspireMD Inc.Quarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
Using data filters to optimize entry into InspireMD Inc.Gap Down & Weekly Return Optimization Plans - newser.com
Director Makes Bold Move with Major Stock Purchase in InspireMD - TipRanks
InspireMD Director Paul Stuka Acquires 13,431 Shares - TradingView
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):